Regenocyte is an international corporation dedicated to leading the world in providing Adult Stem Cell Therapies by utilizing and advancing the most effective and safest technologies and medical procedures possible in order to prolong and improve the lives of its patients.
The word "Regenocyte" is the medical term for Adult Stem Cells (ASC), derived from the Latin term "regeneratus," or "created again," because they are unspecialized cells derived from the patient's own peripheral blood via a standard blood draw or mature tissue such as bone marrow - as opposed to that of embryos - and are capable of self-multiplying into additional cells or becoming almost any type of new cell or tissue. Using this remarkable biological property, Regenocyte Therapeutic can regenerate damaged or failing cells and tissue to create new hope for its patients.
Regenocyte's Adult Stem Cell Therapy is safe, highly effective, and presents minimal risk.
Regenocyte can currently treat cardiac and vascular patients with health problems including:
- Congestive Heart Failure
- Coronary Heart Disease
- Cardiomyopathy
- Angina Pectoris
- Peripheral Artery Disease
- Gangrene
- Wound Care
- Poor Circulation
- Pulmonary Hypertension
- COPD
- Pulmonary Fibrosis
Through its own research and development efforts, Regenocyte Therapeutic is developing cell lines and treatment solutions for a variety of other diseases and disorders including:
- ALS
- Parkinson's
- Alzheimer's
- MS
- Hearing Loss
- Macular Degeneration
- Early Senile Dementia














